Unity Biotechnology, Inc.UBXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank59
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P59
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q1 2025 | 14.00% |
| Q4 2024 | -31.58% |
| Q3 2024 | -22.58% |
| Q2 2024 | 8.82% |
| Q1 2024 | -257.52% |
| Q4 2023 | 90.58% |
| Q3 2023 | 5.61% |
| Q2 2023 | -189.19% |
| Q1 2023 | 63.00% |
| Q4 2022 | 26.47% |
| Q3 2022 | 28.42% |
| Q2 2022 | 32.14% |
| Q1 2022 | -55.56% |
| Q4 2021 | 39.39% |
| Q3 2021 | 7.19% |
| Q2 2021 | -10.34% |
| Q1 2021 | 21.62% |
| Q4 2020 | 28.85% |
| Q3 2020 | -36.84% |
| Q2 2020 | 35.59% |
| Q1 2020 | -51.28% |
| Q4 2019 | 23.53% |
| Q3 2019 | 8.93% |
| Q2 2019 | -27.27% |
| Q1 2019 | 16.98% |
| Q4 2018 | -17.78% |
| Q3 2018 | 40.79% |
| Q2 2018 | -97.40% |
| Q1 2018 | -28.62% |
| Q4 2017 | 91.24% |
| Q3 2017 | 5.58% |
| Q2 2017 | -24.83% |
| Q1 2017 | 0.00% |